Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Capital One Financial Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $89
Capital One Financial analyst Naureen Quibria maintains $Immunocore(IMCR.US)$ with a buy rating, and maintains the target price at $89.According to TipRanks data, the analyst has a success rate of 17.
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
H.C. Wainwright analyst Patrick Trucchio maintains $Immunocore(IMCR.US)$ with a buy rating, and maintains the target price at $100.According to TipRanks data, the analyst has a success rate of 28.3% a
A Quick Look at Today's Ratings for Immunocore(IMCR.US), With a Forecast Between $67 to $92
On May 24, major Wall Street analysts update their ratings for $Immunocore(IMCR.US)$, with price targets ranging from $67 to $92.Barclays analyst Peter Lawson maintains with a buy rating, and maintain
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and Immunocore Holdings (IMCR)
Immunocore Holdings (IMCR) Receives a Buy From Barclays
Analysts Offer Insights on Healthcare Companies: Cresco Labs (OtherCRLBF) and Immunocore Holdings (IMCR)
Optimistic Buy Rating for Immunocore Holdings Amid Promising Brenetafusp Study and Strategic Developments
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)
Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)
Immunocore Holdings Is Maintained at Buy by Mizuho
Immunocore Holdings Is Maintained at Buy by Mizuho
Express News | Immunocore : Mizuho Cuts Target Price to $88 From $90
Immunocore Holdings Plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Last week, you might have seen that Immunocore Holdings plc (NASDAQ:IMCR) released its quarterly result to the market. The early response was not positive, with shares down 2.1% to US$58.95 in the pas
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Aclaris Therapeutics (ACRS) and Immunocore Holdings (IMCR)
Express News | Canaccord Genuity Maintains Hold on Immunocore Hldgs, Raises Price Target to $67
Immunocore Holdings Is Maintained at Buy by HC Wainwright & Co.
Immunocore Holdings Is Maintained at Buy by HC Wainwright & Co.
Buy Rating Affirmed for Immunocore Holdings on Strong KIMMTRAK Sales and Promising Pipeline Growth
Express News | Immunocore Holdings PLC : H.c. Wainwright Raises Target Price to $100 From $90
No Data